VirtualScopics — Q2 2014 Earnings Presentation
11 slides from VirtualScopics's earnings presentation, Aug 14, 2014
Slide 1: Second Quarter 2014 Conference Call
500 Linden Oaks, 2 nd Floor Rochester, New York 14625 (585) 249 - 6231 www.virtualscopics.com NASDAQ: VSCP Second Quarter 2014 Conference Call August 14, 2014 1
Slide 2: Forward-looking statements
The statements contained in this press release that are not purely historical are forward - looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to be covered by the safe h
Slide 3: Awards Outstanding and Bookings
(millions of donarsy (As of June 30, 2014 2013 Awards Outstanding 49 $ 44 Bookings s wes es Awards Outstanding and Bookings s 176° 8 zd jons of dollars) As of June 30, As of Dec 31, 2014 2013 Awards Outstanding and Bookings s 176° 8 20.5 jons of dollars) As of ‘As of Dec 31, Aug 14,2014 2013 Awards
Slide 4: Beneficial Ownership Percentages
15.1% 10.2% 7.1% 5.1% 62.5% Loeb Investors Company Merck Global Health Innovation Fund, LLC University of Rochester Board Members and Executives Stockholders with less than 5% of holdings Beneficial Ownership Percentages As of April 30, 2014 4
Slide 5: Statement of operations: three and six months ended June 30
Revenues, Cost of Services Gross Profit Gross Margin Operating Expenses Research and Development ‘Sales and Marketing General and Administrative Depreciation and Amortization ‘Total Operating Expenses ‘Operating (Loss) Income (thousands or aouarsy ‘Three Months Ended June 30, (thousands or aouarsy ‘
Slide 6: Balance Sheet
lancelSheet) June 30, December 31: 2014 2013 (Unaudited) Assets Current assets ‘Cash $_ 5.573.576 $ 7.330.630 Accounts receivable, net 1.861.735 1.725.070 Prepaid expenses and other current assets 371.341 ‘397.699 ‘Total current assets 7,806.652 TA5S.399 Patents)/net 4.271.586 1.334.420 Property and
Slide 7: 2014 outlook and cash position
x We believe 2014 revenues will be relatively flat with 2013 Timing of the initiation of 2013 and 2014 projects The number of projects that closed during 2013 and the first half of 2014 x We expect operating expenses to trend higher for the remainder of the year Investments in personnel, operations,
Slide 8: Strategic Alliance with IXICO and investments
x Strategic Alliance with IXICO plc signed in June x Joint office opened in New Hope, Pennsylvania Strategically located among many pharmaceutical customers x Joint Scientific Advisory Board finalized with a seven member team x Investments made in People, Operations, Systems and Infrastructure to st
Slide 9: Key focus areas
x The TEAM x Planning/Forecasting Tools x IXICO Alliance – quick win! x PPD – great possibilities x Phase III Wins x Improved Messaging 9
Slide 10: Key takeaways
x Mood of the Industry x Continued Outsourcing from Pharma to CROs x Sound Investments in People & Infrastructure x Trending of Awards and Bookings x The TEAM 10
Slide 11: Your feedback is always appreciated!
Your feedback is always appreciated! 11